What blood investigations are recommended for diagnosing cholestasis in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Investigations for Cholestasis in Pregnancy

Measure serum total bile acids and liver transaminases (ALT/AST) immediately in any pregnant woman presenting with pruritus in the second or third trimester. 1

Essential Laboratory Tests

Primary Diagnostic Tests

Total serum bile acids is the most sensitive and specific marker for intrahepatic cholestasis of pregnancy (ICP), with levels >10 μmol/L considered diagnostic when combined with pruritus and exclusion of other causes. 1

  • Random (non-fasting) samples are acceptable and more convenient than fasting samples, as the difference between fasting and postprandial values is clinically insignificant. 1
  • Enzymatic assay provides results in 4 hours to 4 days and is preferred over mass spectrometry (4-14 days turnaround). 1
  • Bile acid levels >10 μmol/L confirm diagnosis; levels ≥100 μmol/L indicate severe disease requiring delivery at 36 weeks. 1

Liver transaminases (ALT and AST) are typically elevated in ICP but are not required for diagnosis. 1

  • Transaminase levels are usually <500 U/L in ICP. 1
  • ALT is elevated in 100% of cases and AST in 99% of cases based on older diagnostic criteria. 2
  • These support the diagnosis but cannot replace bile acid testing. 1

Additional Laboratory Tests to Exclude Other Conditions

The following tests should be ordered to exclude pregnancy-specific and non-pregnancy-specific causes of elevated liver enzymes: 1

  • Complete blood count with platelets - to exclude HELLP syndrome (hemolysis, elevated liver enzymes, low platelets <50,000/μL). 1
  • Coagulation studies (PT/INR) - to exclude acute fatty liver of pregnancy (AFLP), which presents with coagulopathy. 1
  • Glucose level - hypoglycemia suggests AFLP rather than ICP. 1
  • Bilirubin (total and direct) - typically <5 mg/dL (<85 μmol/L) in ICP; higher levels suggest HELLP or AFLP. 1
  • LDH - normal in ICP; elevated in HELLP syndrome due to hemolysis. 1

Tests for Underlying Hepatobiliary Disease

In women with elevated bile acids before the second trimester or with persistent abnormalities postpartum, additional testing is warranted: 1

  • Gamma-glutamyl transferase (GGT) - typically normal in ICP; elevated GGT suggests ABCB4 deficiency, primary biliary cholangitis (PBC), or primary sclerosing cholangitis (PSC). 1, 3
  • Hepatobiliary ultrasound - to exclude gallstones and biliary obstruction. 1
  • Hepatitis C antibody - women with hepatitis C have 3.5-fold increased risk of ICP. 1
  • Thyroid function tests - to exclude thyroid disorders as a cause of pruritus. 1
  • Renal function tests - to exclude renal disease causing pruritus. 1

Timing and Frequency of Testing

Initial Testing Strategy

Order bile acids and transaminases immediately when ICP is suspected based on pruritus. 1

  • Do not wait for symptoms to worsen before testing. 1
  • If initial bile acids are normal but pruritus persists without alternative explanation, repeat testing every 1-2 weeks until symptoms resolve or diagnosis is confirmed. 1
  • Pruritus can precede bile acid elevation by several weeks. 1

Serial Monitoring After Diagnosis

Measure serum bile acids at least weekly from 32 weeks' gestation to identify concentrations >40 μmol/L, which indicate increased risk of adverse pregnancy outcomes. 1

  • Peak bile acid levels determine delivery timing and fetal surveillance intensity. 1
  • Bile acid levels can increase rapidly during pregnancy, particularly near term. 1

Critical Diagnostic Pitfalls to Avoid

Never diagnose ICP or make delivery decisions based on pruritus alone without laboratory confirmation of elevated bile acids. 1

  • Delivering before 37 weeks based on clinical suspicion alone without elevated bile acids leads to unnecessary preterm deliveries with associated neonatal morbidity. 1
  • Normal initial labs do not permanently rule out ICP if symptoms persist. 1

Always exclude HELLP syndrome and AFLP before assuming ICP, as these conditions carry significant maternal mortality risk and require immediate delivery. 1

  • HELLP presents with hemolysis, elevated LDH, low platelets, and elevated transaminases. 1
  • AFLP presents with liver failure, coagulopathy, hypoglycemia, and encephalopathy. 1

Distinguish excoriations from scratching from primary dermatologic rashes. 1

  • ICP causes pruritus without a primary rash, only secondary excoriations. 1
  • Presence of a primary rash suggests dermatologic conditions rather than ICP. 1

Postpartum Follow-Up Testing

Repeat bile acids and liver transaminases 4-6 weeks postpartum if symptoms or abnormal laboratory values persist. 1

  • ICP typically resolves completely after delivery. 1
  • Persistent abnormalities suggest underlying chronic liver disease (PBC, PSC, ABCB4 deficiency, chronic hepatitis C) that was unmasked by pregnancy. 1
  • Refer to hepatology if results remain abnormal at 6 weeks postpartum. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Serum bile acids in cholestasis of pregnancy.

Obstetrics and gynecology, 1977

Related Questions

What is the workup for cholestasis of pregnancy?
What is the diagnosis and treatment approach for pregnancy cholestasis?
What is the management and treatment for a pregnant woman diagnosed with cholestasis of pregnancy?
What is the management approach for a patient with chronic right upper quadrant pain and significantly elevated Gamma-Glutamyl Transferase (GGT) levels following cholecystectomy?
What is the management plan for cholestasis of pregnancy (intrahepatic cholestasis of pregnancy, ICP)?
What is the most likely diagnosis for an elderly female with anemia, normocytic anemia (normal Mean Corpuscular Volume (MCV)), and schistocytes on blood smear?
What is the best management approach for a patient with gastroesophageal reflux disease (GERD) and mild hyperthyroidism, currently taking propranolol, and with lifestyle factors including daily smoking, caffeine, and soda consumption?
What is the differential diagnosis and management for a 53-year-old patient with a history of Hypertension (HTA) and Dyslipidemia, presenting with memory problems, a normal clinical exam, and an MRI showing a rounded image in the left temporal region with a hypodense center, peripheral ring, and prelesional edema?
What is the recommended antibiotic for an elderly patient with a history of streptococcal (strep) bacteremia and current streptococcal pharyngitis?
What are the risks and treatment options for an unmanaged anaphylaxis patient?
What are common OPD (Outpatient Department) diagnoses in a private provincial hospital?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.